Back to results
US 2012/0071413 A1Published application
TREATMENT OF CHRONIC NEPHROPATHIES USING SOLUBLE COMPLEMENT RECEPTOR TYPE I (sCR1)
AssigneesCelldex Therapeutics, Inc., University of Iowa Research Foundation
InventorsRichard J. H. Smith, Yuzhou Zhang, Henry C. Marsh
Life of this patent
Estimating the term…
Abstract
A method is disclosed for treating nephropathies involving undesired alternative pathway complement activation by administration of a complement inhibitory protein such as soluble complement receptor type I (sCR1).
Claims20
A method for treating nephropathy characterized by undesired alternative pathway complement activation in a mammalian subject comprising administering to a mammalian subject in need of treatment an effective amount of a soluble complement receptor type I (sCR1) polypeptide.
Dependencies are inferred from the claim text.